Check out our most popular compounded medications! Get Started
Morphine Sulfate 20 mg Slow Release Capsules (Gluten Free) are designed to manage conditions such as chronic pain, cancer pain, arthritis, fibromyalgia, and neuropathic pain. These capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This formulation offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Morphine Sulfate 20 mg Slow Release Capsules (Gluten Free) is a compounded medication specifically designed to manage a variety of chronic and acute pain conditions. This includes chronic pain, cancer pain, postoperative pain, neuropathic pain, and arthritis pain. The medication is formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the active ingredient, morphine sulfate, over an extended period of time. This slow release mechanism offers sustained therapeutic effects.
The reduced dosing frequency due to the slow release formulation not only enhances patient compliance but also improves the overall treatment outcomes for medications requiring a controlled and prolonged release profile. Furthermore, these capsules are gluten free, making them a suitable choice for patients with gluten sensitivities or allergies. This careful consideration of dietary restrictions underscores our commitment to patient-centered care and personalized medication solutions.
If you have any questions or concerns about Morphine Sulfate 20 mg Slow Release Capsules (Gluten Free) or any other medication, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is always ready to assist and provide the necessary guidance to ensure optimal medication use and patient safety.
Morphine Sulfate 20 mg Slow Release Capsules (Gluten Free) is a potent opioid analgesic, primarily prescribed for the management of moderate to severe pain conditions such as Chronic Pain, Cancer Pain, Postoperative Pain, Neuropathic Pain, and Arthritis Pain. As a full opioid agonist, Morphine Sulfate exhibits a relative selectivity for the mu-opioid receptor, although it can interact with other opioid receptors at higher doses. The drug is metabolized in the liver through the process of glucuronidation and is subsequently excreted in the urine.
The unique formulation of these capsules incorporates Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the encapsulated Morphine Sulfate over an extended period of time. This sustained release mechanism offers several benefits including consistent therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
The most common of these include constipation, nausea, vomiting, dizziness, drowsiness, and dry mouth. It is crucial for patients to be monitored for signs of opioid toxicity, which may manifest as respiratory depression, sedation, and confusion. Additionally, signs of opioid abuse or misuse such as euphoria, increased energy, and increased libido should be vigilantly observed for.
It is important to consult with a healthcare professional for any questions or concerns regarding the use of Morphine Sulfate 20 mg Slow Release Capsules (Gluten Free) for the treatment of Chronic Pain, Cancer Pain, Postoperative Pain, Neuropathic Pain, and Arthritis Pain.
Morphine Sulfate 20 mg Slow Release Capsules (Gluten Free) is a potent, extended-release opioid analgesic designed to manage moderate to severe chronic pain, cancer pain, postoperative pain, neuropathic pain, and arthritis pain. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow-release mechanism provides a consistent level of pain relief throughout the day, reducing the need for frequent dosing and enhancing patient compliance.
These capsules are gluten-free, making them an appropriate choice for individuals with gluten sensitivities or allergies. It is crucial to take this medication exactly as prescribed by your healthcare provider. The capsules should be swallowed whole with a full glass of water, without crushing, chewing, or breaking them. Consuming the capsules with food may help mitigate potential side effects such as nausea and vomiting. Consistent timing in taking the medication each day is recommended to maintain a steady level of pain relief.
Patients should be aware that Morphine Sulfate 20 mg Slow Release Capsules (Gluten Free) may cause side effects such as constipation, dizziness, drowsiness, and nausea. If any of these side effects occur, it is important to consult your healthcare provider. Furthermore, this medication has the potential for addiction, abuse, and misuse, emphasizing the importance of taking the medication strictly as prescribed and not sharing it with others.
Healthcare providers should note that Morphine Sulfate 20 mg Slow Release Capsules (Gluten Free) can interact with other medications, including certain antibiotics, antifungals, and antidepressants. Therefore, a thorough review of a patient’s medication list is necessary before prescribing this medication. Additionally, this medication can cause respiratory depression and should be used with caution in patients with respiratory conditions.
If you have any questions or concerns about Morphine Sulfate 20 mg Slow Release Capsules (Gluten Free), please do not hesitate to reach out for further information.
Morphine Sulfate 20 mg Slow Release Capsules (Gluten Free) is a compounded formulation of the pain medication morphine. It is designed to release the active ingredient gradually over an extended period of time, offering sustained therapeutic effects.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It is designed to release the encapsulated medication gradually over an extended period of time, reducing the dosing frequency and improving patient compliance for medications requiring a controlled and prolonged release profile.
'Slow release' refers to the gradual release of the active ingredient from the capsule over an extended period of time. This offers sustained therapeutic effects and reduces the need for frequent dosing.
A slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
Yes, Morphine Sulfate 20 mg Slow Release Capsules are gluten-free, making them suitable for individuals with gluten intolerance or celiac disease.
The dosing frequency of Morphine Sulfate 20 mg Slow Release Capsules will depend on your specific medical condition and response to treatment. Always follow your healthcare provider's instructions.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
No, breaking or crushing the capsules can interfere with the controlled-release mechanism and may lead to rapid release and absorption of a potentially fatal dose of morphine.
Common side effects may include constipation, nausea, sleepiness, vomiting, tiredness, headache, dizziness, abdominal pain. You should contact your healthcare provider if you experience any unusual or severe side effects.
Morphine Sulfate 20 mg Slow Release Capsules should only be used during pregnancy or while breastfeeding if the potential benefits justify the potential risks to the fetus or baby. Always consult your healthcare provider before starting any new medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
